MCL-1 Modulating compounds for Cancer Treatment - Archive ouverte HAL Access content directly
Patents Year : 2015

MCL-1 Modulating compounds for Cancer Treatment

Composés modulant MCL-1 utilisés dans le traitement du cancer

(1) , (2) , (2) , (2) , (2) , (2) , (2) , (2) , (2) , (3) , (3)
1
2
3

Domains

Life Sciences [q-bio] Cancer

Elizabeth Bernardo  : Connect in order to contact the contributor

https://www.hal.inserm.fr/inserm-02545373

Submitted on : Friday, April 17, 2020-8:41:17 AM

Last modification on : Wednesday, November 23, 2022-6:10:04 PM

Not file

Dates and versions

inserm-02545373 , version 1 (17-04-2020)

Identifiers

  • HAL Id : inserm-02545373 , version 1

Cite

Laurent Poulain, Anne-Sophie Voisin-Chiret, Jana Sopkova de Oliveira Santos, Ronan Bureau, Grégory Burzicki, et al.. MCL-1 Modulating compounds for Cancer Treatment. France, Patent n° : WO 2015/132727. 2015. ⟨inserm-02545373⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-NANTES CNRS UNIV-ANGERS COMUE-NORMANDIE CRCINA UNICAEN NANTES-UNIVERSITE
31 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More